Teva To Pay $450M To Settle Kickback Cases

By Julie Manganis · October 10, 2024, 4:54 PM EDT

Pharmaceutical giant Teva will pay $450 million to settle allegations it violated the False Claims Act by fixing the prices of several generic drugs and by raising the price of a...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Case Information

Case Title

UNITED STATES OF AMERICA v. TEVA PHARMACEUTICALS USA, INC. et al

Case Number

Court

Massachusetts

Nature of Suit

Other Statutes: False Claims Act

Date Filed

August 18, 2020

Recent Articles By Julie

October 17, 2024
Ex-Genzyme Exec Says Anxiety Disclosure Led To Firing
October 15, 2024
Motley Rice May Avoid DQ In Boston Opioid Case, Judge Hints
October 08, 2024
Mass. Seeks Order Forcing Steward To Maintain Coverage
September 24, 2024
Moderna Execs Hyped Ineffective RSV Vax, Suit Says
September 23, 2024
Mass. General Asks Court To End Fat Removal Patent License
September 18, 2024
Mass. Appeals Court Backs Pot Shop's Arbitration Agreement
September 06, 2024
Abortion Provider Says Activist Group Intercepted Patient Info
August 19, 2024
MOVEit MDL Judge's Call For Order Met With Atty Squabbles
August 05, 2024
CooperSurgical Says Lab Hid Flawed IVF Product Tests
August 01, 2024
AbbVie Wants Mass. Biotech Firm To Pay Up For Drug Work